FIELD: medicine.
SUBSTANCE: method involves determining acid-alkaline equilibrium pH on conjunctiva surface subjected to hyperemia most of all. The value being equal to 8.0-12.0, acute chlamydiosis stage is to be diagnosed. The value being equal to 5.1-6.0, subacute chlamydiosis stage is to be diagnosed. The value being equal to 7.43, acute candidiasis stage is to be diagnosed. The value being equal to 6.21, subacute candidiasis stage is to be diagnosed. The value being equal to 8.18, acute toxoplasmosis stage is to be diagnosed. The value being equal to 5.46, subacute toxoplasmosis stage is to be diagnosed. The value being equal to 3.45, acute mycoplasmosis stage is to be diagnosed. The value being equal to 4.52, subacute mycoplasmosis stage is to be diagnosed. The value being equal to 6.0-6.8, acute inflammation stage is to be diagnosed. The value being equal to 4.75, subacute inflammation stage is to be diagnosed.
EFFECT: high accuracy of differential diagnosis.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL DIAGNOSIS OF AGE AND COMPLICATED CATARACT | 2017 |
|
RU2690152C2 |
METHOD OF EXPERIMENTAL DIFFERENTIAL STADIAL DIAGNOSTICS OF WOUND PROCESS ASSOCIATED WITH TREATMENT OF EYE PENETRATING WOUNDS | 2007 |
|
RU2330293C1 |
METHOD OF DETERMINING STAGES OF WOUND PROCESS IN TREATMENT OF PENETRATING EYE WOUNDS IN EXPERIMENT | 2008 |
|
RU2372833C1 |
METHOD OF DETERMINATION OF COMPLEX OF ETIOLOGICAL FACTORS LEADING TO DEVELOPMENT OF SPECIFIC CHRONIC INFLAMMATORY DISEASES OF ANTERIOR EYE CREST | 2007 |
|
RU2337609C2 |
METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 |
|
RU2421193C2 |
METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
EYE DROPS, WHICH HAVE ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTION | 2012 |
|
RU2493823C1 |
METHOD FOR PREDICTING AEROBIC VAGINITIS | 2003 |
|
RU2241990C1 |
OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
METHOD FOR PREDICTION OF RISK OF CONGENITAL INFECTIONS | 2013 |
|
RU2532382C1 |
Authors
Dates
2004-12-10—Published
2003-07-11—Filed